𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

✍ Scribed by Andrew D. Norden; Jeffrey J. Raizer; Lauren E. Abrey; Kathleen R. Lamborn; Andrew B. Lassman; Susan M. Chang; W. K. Alfred Yung; Mark R. Gilbert; Howard A. Fine; Minesh Mehta; Lisa M. DeAngelis; Timothy F. Cloughesy; H. Ian Robins; Kenneth Aldape; Janet Dancey; Michael D. Prados; Frank Lieberman; Patrick Y. Wen

Book ID
106481447
Publisher
Springer US
Year
2009
Tongue
English
Weight
263 KB
Volume
96
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II and pharmacodynamic study of
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d